BRIEF-FDA Says Medtronic Removes Unused 027 Compatible Pipeline Vantage Embolization Device With Shield Technology

Important legal information about the email you will be sending. By using this service, you agree to input your real email address and only send it to people you know. It is a violation of law in some jurisdictions to falsely identify yourself in an email. All information you provide will be used by Fidelity solely for the purpose of sending the email on your behalf. The subject line of the email you send will be "Fidelity.com: "

BRIEF-FDA Says Medtronic Removes Unused 027 Compatible Pipeline Vantage Embolization Device With Shield Technology

, Reuters - 2:27 PM ET 3/18/2025 default

March 18 (Reuters) - FDA:

* MEDTRONIC REMOVES UNUSED 027 COMPATIBLE PIPELINE VANTAGE EMBOLIZATION DEVICE WITH SHIELD TECHNOLOGY

* MEDTRONIC UPDATES USE INSTRUCTIONS FOR 021 COMPATIBLE PIPELINE VANTAGE EMBOLIZATION DEVICES

* MEDTRONIC UPDATES INSTRUCTIONS FOR USING PIPELINE VANTAGE 021 DEVICE MODELS DUE TO RISK OF INCOMPLETE WALL APPOSITION & BRAID DEFORMATION

* IDENTIFIED MEDTRONIC'S EMBOLIZATION DEVICE RECALL AS THE MOST SERIOUS TYPE

* FOUR REPORTED INJURIES, NO REPORTS OF DEATH RELATED TO MEDTRONIC'S 021 COMPATIBLE PIPELINE VANTAGE EMBOLIZATION DEVICE

* THIRTEEN REPORTED INJURIES, FOUR REPORTS OF DEATH RELATED TO MEDTRONIC'S 027 COMPATIBLE PIPELINE VANTAGE EMBOLIZATION DEVICE Further company coverage:

(c) Reuters 2025. All rights reserved. Republication or redistribution of Reuters content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters and the Reuters sphere logo are registered trademarks and trademarks of the Reuters group of companies around the world.